Matches in SemOpenAlex for { <https://semopenalex.org/work/W2914469059> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2914469059 endingPage "1076" @default.
- W2914469059 startingPage "1076" @default.
- W2914469059 abstract "Catheter ablation is an evolving therapeutic strategy for the management of atrial fibrillation (AF). It is associated with a risk of thromboembolic events. The peri-procedural anticoagulation management with warfarin has been successful in mitigating this risk. However, introduction of novel oral anticoagulants like dabigatran offers more flexibility in anticoagulation approaches. Previous studies had evaluated the safety and efficacy of dabigatran in the radiofrequency ablation, but data related to cryoballoon ablation is lacking.We performed a retrospective observational study involving patients who underwent cryoballoon ablation for drug-refractory, symptomatic AF while on dabigatran in periprocedural period. Thromboembolic, hemorrhagic or other complications occurring within the first 30 days after the ablation procedure were analyzed. Our study population comprised of 50 patients with mean age of 58.96 ± 3.54 years with 76% (n=38) being male. We found 3 (6%) minor complications in peri-procedural period including 2 groin hematomas and 1 trace asymptomatic pericardial effusion. There were no major intraprocedural or post procedural hemorrhagic or thromboembolic events. None of patients with the minor complications required significant additional workup or extended hospital stay. All the patients were able to continue dabigatran for 30 days without any additional side effects or complications.Dabigatran is a safe and efficacious agent in patients undergoing cryoballoon AF ablation." @default.
- W2914469059 created "2019-02-21" @default.
- W2914469059 creator A5031786138 @default.
- W2914469059 creator A5043088949 @default.
- W2914469059 creator A5048769040 @default.
- W2914469059 creator A5052581283 @default.
- W2914469059 creator A5062699649 @default.
- W2914469059 creator A5079972383 @default.
- W2914469059 date "2014-06-30" @default.
- W2914469059 modified "2023-09-23" @default.
- W2914469059 title "The Rate Of Complications Associated With Concomitant Use Of Dabigatran With Cryoballoon Ablation For Atrial Fibrillation." @default.
- W2914469059 cites W108371223 @default.
- W2914469059 cites W146672770 @default.
- W2914469059 cites W1489535640 @default.
- W2914469059 cites W1595057647 @default.
- W2914469059 cites W1984998328 @default.
- W2914469059 cites W2012840541 @default.
- W2914469059 cites W2072636615 @default.
- W2914469059 cites W2073966130 @default.
- W2914469059 cites W2103329068 @default.
- W2914469059 cites W2112450983 @default.
- W2914469059 cites W2115459043 @default.
- W2914469059 cites W2134286898 @default.
- W2914469059 cites W2144939065 @default.
- W2914469059 cites W2159819222 @default.
- W2914469059 cites W2166603122 @default.
- W2914469059 cites W2572139654 @default.
- W2914469059 doi "https://doi.org/10.4022/jafib.1076" @default.
- W2914469059 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5135155" @default.
- W2914469059 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27957086" @default.
- W2914469059 hasPublicationYear "2014" @default.
- W2914469059 type Work @default.
- W2914469059 sameAs 2914469059 @default.
- W2914469059 citedByCount "2" @default.
- W2914469059 countsByYear W29144690592015 @default.
- W2914469059 countsByYear W29144690592018 @default.
- W2914469059 crossrefType "journal-article" @default.
- W2914469059 hasAuthorship W2914469059A5031786138 @default.
- W2914469059 hasAuthorship W2914469059A5043088949 @default.
- W2914469059 hasAuthorship W2914469059A5048769040 @default.
- W2914469059 hasAuthorship W2914469059A5052581283 @default.
- W2914469059 hasAuthorship W2914469059A5062699649 @default.
- W2914469059 hasAuthorship W2914469059A5079972383 @default.
- W2914469059 hasConcept C126322002 @default.
- W2914469059 hasConcept C141071460 @default.
- W2914469059 hasConcept C164705383 @default.
- W2914469059 hasConcept C2776131983 @default.
- W2914469059 hasConcept C2776301958 @default.
- W2914469059 hasConcept C2778810321 @default.
- W2914469059 hasConcept C2778902805 @default.
- W2914469059 hasConcept C2779161974 @default.
- W2914469059 hasConcept C2779384505 @default.
- W2914469059 hasConcept C2908647359 @default.
- W2914469059 hasConcept C71924100 @default.
- W2914469059 hasConcept C99454951 @default.
- W2914469059 hasConceptScore W2914469059C126322002 @default.
- W2914469059 hasConceptScore W2914469059C141071460 @default.
- W2914469059 hasConceptScore W2914469059C164705383 @default.
- W2914469059 hasConceptScore W2914469059C2776131983 @default.
- W2914469059 hasConceptScore W2914469059C2776301958 @default.
- W2914469059 hasConceptScore W2914469059C2778810321 @default.
- W2914469059 hasConceptScore W2914469059C2778902805 @default.
- W2914469059 hasConceptScore W2914469059C2779161974 @default.
- W2914469059 hasConceptScore W2914469059C2779384505 @default.
- W2914469059 hasConceptScore W2914469059C2908647359 @default.
- W2914469059 hasConceptScore W2914469059C71924100 @default.
- W2914469059 hasConceptScore W2914469059C99454951 @default.
- W2914469059 hasIssue "1" @default.
- W2914469059 hasLocation W29144690591 @default.
- W2914469059 hasOpenAccess W2914469059 @default.
- W2914469059 hasPrimaryLocation W29144690591 @default.
- W2914469059 hasRelatedWork W1990046369 @default.
- W2914469059 hasRelatedWork W2003081601 @default.
- W2914469059 hasRelatedWork W2004952918 @default.
- W2914469059 hasRelatedWork W2031786650 @default.
- W2914469059 hasRelatedWork W2052931751 @default.
- W2914469059 hasRelatedWork W2057980839 @default.
- W2914469059 hasRelatedWork W2111589073 @default.
- W2914469059 hasRelatedWork W2292664286 @default.
- W2914469059 hasRelatedWork W2583047656 @default.
- W2914469059 hasRelatedWork W2473276012 @default.
- W2914469059 hasVolume "7" @default.
- W2914469059 isParatext "false" @default.
- W2914469059 isRetracted "false" @default.
- W2914469059 magId "2914469059" @default.
- W2914469059 workType "article" @default.